WO2014087421A2 - Stable hydrophilic medium-soluble composition and the use thereof - Google Patents

Stable hydrophilic medium-soluble composition and the use thereof Download PDF

Info

Publication number
WO2014087421A2
WO2014087421A2 PCT/IN2013/000515 IN2013000515W WO2014087421A2 WO 2014087421 A2 WO2014087421 A2 WO 2014087421A2 IN 2013000515 W IN2013000515 W IN 2013000515W WO 2014087421 A2 WO2014087421 A2 WO 2014087421A2
Authority
WO
WIPO (PCT)
Prior art keywords
composition
group
component
hydrophilic
hydrophilic medium
Prior art date
Application number
PCT/IN2013/000515
Other languages
French (fr)
Other versions
WO2014087421A3 (en
Inventor
Vishal Joshi
Milind Vaidya
Vivek RAJE
Original Assignee
Dow Corning India Private Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning India Private Limited filed Critical Dow Corning India Private Limited
Publication of WO2014087421A2 publication Critical patent/WO2014087421A2/en
Publication of WO2014087421A3 publication Critical patent/WO2014087421A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585Organosilicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/893Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by an alkoxy or aryloxy group, e.g. behenoxy dimethicone or stearoxy dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Definitions

  • the present invention relates to a stable hydrophilic medium-soluble composition of a hydrophobic physiologically active ingredient comprising (A) hydrophobic physiologically active ingredient; (B) silicone compound having specific hydrophilic group (preferably polyether group); and (C) silane having specific hydrophilic group (preferably, having at least two or more polyether group in a silane molecule).
  • Insoluble hydrophobic physiologically active ingredient are stabilized by a combination of said component (B) and (C) in the hydrophilic medium selected from water, alcohols and a mixture thereof without crystallization.
  • the obtained clear hydrophilic medium-soluble composition is useful as a cosmetic raw material or quasi-drug raw material in the personal and health care industries.
  • the hydrophobic physiologically active ingredient is hair-growing agent (ex. Minoxidil), and the hydrophilic medium-soluble composition is applied as a raw material for hair cosmetics or quasi-drugs for human skin of the head.
  • Minoxidil (6-piperidin-l-ylpyrimidine-2, 4-diamine 3-oxide) or other water-insoluble hair growing agent is a vasodilator medication known for its ability to slow or stop hair loss and promote hair re-growth. It is available over the counter for treatment of androgenic alopecia, among other baldness treatments. Then, Minoxidil needs to be applied once or twice daily for the hair gain to be maintained. For maximum effect, the solution should be in contact with the scalp for four hours before being washed out.
  • DHT dihydro testosterone
  • 5-alpha reductase the enzyme responsible for its accumulation around the hair follicle
  • Minoxidil solution in highly-concentrated form.
  • Minoxidil has poor solubility in water or other hydrophilic medium. For this, it is difficult to increase the concentration of physiologically active ingredient to 5 or more % in the solution. Furthermore, during its storage term, insoluble active ingredients are precipitated in the product and caused a heavy crystallization. Furthermore, the obtained Minoxidil solution appears to be unclear and its acceptable usage is fairly limited in a personal-care and/or health-care product. Additionally, Minoxidil products involve contact with hair strands, which may cause problems with hair styling since minoxidil must be in an alcohol solution and on evaporation minoxidil is crystallized and on light exposure, converts to dark brown material. This is one of the biggest challenges for formulators to keep minoxidil in soluble form after applications.
  • WO2009/101497 discloses a fixed topical composition which contains minoxidil, aminexil, siloxanes, and silicone elastomers.
  • WO03055454A1 teaches to the use of lipophillic components selected from fatty acids comprising 14-20 carbon atoms and dimethyl polysiloxane (mixtures thereof).
  • US6740318 teach an efficacy-enhancing additive (specific silicone based compound) for hair growing agent and a hair growing agent composition containing it.
  • the additive is capable to secure the hair growing effect, even if the content of the pharmaceutically active components is reduced from that of the conventional hair growing agent composition, hence the side-effect thereof could be reduced, and to the hair growing agent composition containing it.
  • hydrophobic physiologically active ingredient is effectively stabilized by using a combination of specific hydrophilic silicone and specific hydrophilic silane in a clear solution. Furthermore, with said combination of three components, hydrophilic medium-soluble composition with high-content of bioactive ingredient is easily obtained by conventional method for personal-care and/or health care products. The obtained composition appears to be clear and stable after storage without any crystallization of bioactive ingredients.
  • the invention is for a stable hydrophilic medium-soluble composition of a hydrophobic physiologically active ingredient comprising:
  • r is a number ranging from 1 to 6,
  • W represents a hydrogen atom or an Ci-C 20 alkyl group
  • (C) at least one silane having a hydrophilic group which binds to a silicone atom via a linkage group with two or more valences and comprise at least one hydrophilic unit selected from hydrophilic units represented by said structural formulae (1) to (4).
  • said components (A) to (C) are dispersed into (D) hydrophilic medium selected from water, alcohols and a mixture thereof in the composition.
  • the preferred component (A) is water-insoluble hair-growing agent (ex. Minoxidil)
  • the preferred component (B) is polyether-modified silicone represented by specific structural formulae
  • the preferred component (C) is polyether-modified silane having two or more polyether groups in a silane molecule.
  • the composition further comprises (E) an organic acid to adjust its pH into acidic state.
  • the amount of component (A) is 0.5 to 30 % by weight of total amount of the composition
  • the amount of component (B) is 1.0 to 30 % by weight of total amount of the composition
  • the amount of component (C) is 0.1 to 10 % by weight of total amount of the composition.
  • the amount of component (A) is increased to 5.0 or more % by weight of total amount of the composition.
  • Most preferable weight range of component (A) is from 7.5 to 15.0 % by weight of total amount of the composition.
  • the present invention relates to a stable hydrophilic medium-soluble composition of a hydrophobic physiologically active ingredient comprising:
  • (B) at least one silicone compound having a hydrophilic group which binds to a silicone atom via a linkage group with two or more valences and comprise at least one hydrophilic unit selected from hydrophilic units represented by the following structural formulae (l) to (4):
  • r is a number ranging from 1 to 6,
  • W represents a hydrogen atom or an Ci-C 2 o alkyl group
  • (C) at least one silane compound having a hydrophilic group which binds to a silicone atom via a linkage group with two or more valences and comprise at least one hydrophilic unit selected from hydrophilic units represented by said structural formulae (l) to (4).
  • Component (A) is at . least one of water-insoluble hair-growing agent.
  • component A is Minoxidil.
  • hair-growing agent can be exemplified by water-insoluble hair-growing agents such as mononitroguaiacol, resorcinol, g-aminobutyric acid, benzethonium chloride, mexiletine hydrochloride, auxin, female hormones, cantharis tincture, cyclosporine, zinc pyrithione, hydrocortisone, polyoxyethylene sorbitan monostearate, peppermint oil, and sasanishiki extract.
  • two or more hair-growing agents may be used in combination for advantageous hair-growing effect on human scalp.
  • Component (B) is a silicone compound having a hydrophilic group such as polyether-modified silicones, mono- or polyvalent alcohol-modified silicones, monoglycerol-modified silicones, diglycerol-modified silicones, polyglycerol-modified silicones, sugar-alcohol modified silicones, polysiloxane-polyoxyalkylene block copolymers.
  • a hydrophilic group such as polyether-modified silicones, mono- or polyvalent alcohol-modified silicones, monoglycerol-modified silicones, diglycerol-modified silicones, polyglycerol-modified silicones, sugar-alcohol modified silicones, polysiloxane-polyoxyalkylene block copolymers.
  • polyether-modified silicone (B2) is represented by the following structural formulae (5):
  • Q represents polyether group represented by following formula (6):
  • each of tl and t2 is independently a number of 0 or more
  • tl+t2 is a number ranging from 4 to 50, preferably 6 to 30,
  • W represents a hydrogen atom or an Ci-C 2 o alkyl group, preferably a hydrogen atom or methyl group,
  • R is a group selected from R 1 , Q and -OH,
  • n is a number ranging from 1 to 50, preferably 1 to 30, more preferably 1 to 20.
  • Component (C) is a silane compound having a hydrophilic group.
  • the silane compound has two or more defined hydrophilic group in a molecule.
  • Other groups binding to Si atom may be selected from Ci-C 20 alkyl group, phenyl group, hydroxyl (- OH) group, C1-C4 alkoxy group and Chloride.
  • Hydrophilic group of component (C) is preferably selected from polyether-group, mono- or polyvalent alcohol- group, monoglycerol- group, diglycerol- group, polyglycerol- group and sugar-alcohol group.
  • Component C may be a polyether-modified silane.
  • the silane has two or more defined hydrophilic group in a molecule and represented as following:
  • tl and t2 is independently a number of 0 or more
  • tl+t2 is a number ranging from 4 to 50, preferably 6 to 30,
  • r is a number of 1 to 6, preferably 2 to 3,
  • p is a number of 2 to 4, preferably 2 to 3, most preferably 2,
  • R 2 independently represents Ci-C 20 alkyl group, phenyl group, hydroxyl(-OH) group, d- C4 alkoxy group or Chloride, Preferably R 2 independently represents methyl group or ethyl group,
  • W represents a hydrogen atom or an C1-C20 alkyl group, preferably a hydrogen atom or methyl group.
  • the hydrophilic medium-soluble composition Component (D) is a hydrophilic medium selected from water, alcohols and a mixture thereof.
  • water, ethanol, isopropanol, 1,3-butylene glycol, sorbitol, dipropylene glycol, glycerol, and polyethylene glycol may be used as component (D) that are able to increase the stability of the inventive composition.
  • water, 1,3-butylene glycol, sorbitol, dipropylene glycol, glycerol, and polyethylene glycol may be used as component (D) as they additionally have a moisturizing effect.
  • the water should be clean and free of components toxic to humans and can be exemplified by tap water, purified water, and mineral water.
  • the hydrophilic medium-soluble composition may further comprise Component (E) which is preferably organic acids.
  • the organic acid may be selected from the group consisting of acetic acid, lactic acid, citric acid, ascorbic acid, malic acid, tartaric acid, and so forth.
  • the pH should be adjusted, preferably in the ranges from 2 to 7 (acidic) to stabilize component (A).
  • Component (A) is much stable at lower pH.
  • the weight ratio of component (A), (B), and (C) in the composition preferably ranges from 0.5 to 30 % by weight of total amount of the composition, from 1.0 to 30 % by weight of total amount of the composition, and from 0.1 to 10 % by weight of total amount of the composition, respectively.
  • composition of the present invention has the capability to be used in personal-care and/or health-care products.
  • the composition of the present invention can comprise any combination of the aforementioned components (A) to (D) and at least any one of the following components; oil agents (including fats and oils, higher fatty acids, higher alcohols, fluorine-based oils and the like); other surfactants (at least one type selected from the group consisting of anionic surfactants, cationic surfactants, nonionic surfactants, amphoteric surfactants and semi-polar surfactants); water-soluble polymers; thickening and/or gelling agents; powders; solid silicone resins or crosslinking organopolysiloxanes; UV-ray protective components; oxidation hair dyes; direct dyes; organic resins, moisture- retaining agents, preservative, anti-microbial agents, perfumes, salts, oxidants or antioxidants, pH adjusting agents, chelating agents, algefacients, anti-inflammatory agents, physiologically active components (such as whitening
  • the most preferred form of using the composition is when the composition comprises Minoxidil in high concentration and is applied to human hair or human scalp as cosmetic or a quasi-drug for scalp treatment.
  • the forms of the cosmetic or quasi-drug of the present invention are not particularly restricted, and may be in the form of liquids, creams, solids, pastes, gels, powders, lamellas, mousses, sprays, sheets, and the like.
  • the cosmetic or quasi-drug of the present invention can be exemplified by hair-restoring agents, hair growth agents, hair tonics, hair oil, skin ageing inhibitors, scalp-care oils, scalp soap, scalp cleansing agents, scalp treatment agents, ointments, shampoos, rinses, hair- treatments and the like but are not limited to the preceding.
  • Example 1 Preparation of Minoxidil-comprising composition
  • Table 1 shows the effect of solubility of Minoxidil in various component (a) or (b) and crystallization and degradation observations.
  • SPE (bl) is PEG-12 Dimethicone represented by bellow formula:
  • Ql represents - (C 2 H 4 0)i 2 H
  • SPE (b2) is polyether-modified silicone represented by bellow formula:
  • Q2 represents - (C 2 H 4 0)i 2 (C 3 H 6 0)i 2 -H
  • SAW (cl) is Bis-PEG(18) mehyl ethyl Dimethyl silane.
  • Example 2 Formulation for 10% Minoxidil Gel
  • Carbopol 940TM 2% solution was prepared in water to obtain Phase A.
  • Phase B was prepared by first mixing Minoxidil, Benzyl alcohol, Propylene glycol, Ethanol and water together. The mixture was stirred till clear solution was obtained. SPE (bl) and SAW (cl) were added in the mixture and stirred. All other ingredients were added to obtain a clear gel.
  • Example 3 Formulation for 10% Minoxidil foam
  • Phase A was prepared by mixing Minoxidil, Benzyl alcohol, Propylene glycol, Ethanol and water together. The mixture is stirred till a clear solution is obtained. SPE (bl) and SAW (cl) were added in the same and stirred. All other ingredients were added to get a clear solution. Phase B was prepared and added to Phase A slowly and packed with tetra fluroethene to get a stable foam. [0032] Example 4 : Formulation for 10% Minoxidil Solution (hydrous)
  • Phase A All the ingredients of Phase A, Phase B, and Phase C were mixed in a separate beaker.
  • Phase B was added to Phase A solution and stirred till a clear solution was obtained.
  • Phase C was added to Phase A-Phase B mixture and stirred till a clear solution is obtained. This solution was heated for about 40-45°C and the temperature was maintained. Minoxidil was added to the above solution slowly, while continuously stirring it for 20 minutes till a clear solution is obtained. The clarity must be checked to ensure complete dissolution of the drug.
  • Example 5 Formulation for 10% Minoxidil solution (anhydrous)
  • Phase A All the ingredients of Phase A, Phase B, and Phase C were mixed in a separate beaker.
  • Phase B was added to Phase A solution and stirred till a clear solution was obtained.
  • This solution was heated for about 40-45°C and the temperature was maintained.
  • Minoxidil was added to the above solution slowly, while continuously stirring it for 20 minutes till a clear solution is obtained. The clarity must be checked to ensure complete dissolution of the drug.
  • Example 6 Formulation for 10% Minoxidil solution (anhydrous)
  • Phase A All the ingredients of Phase A, Phase B, and Phase C were mixed in a separate beaker.
  • Phase B was added to Phase A solution and stirred till a clear solution was obtained.
  • This solution was heated for about 40-45°C and the temperature was maintained.
  • Minoxidil was added to the above solution slowly, while continuously stirring it for 20 minutes till a clear solution is obtained. The clarity must be checked to ensure complete dissolution of the drug.
  • the instant invention relates to a stable hydrophilic medium-soluble composition of a hydrophobic physiologically active ingredient having excellent compatibility with hydrophilic medium and maintains a clear appearance after storage at a high concentration of said active ingredient.
  • the said composition may be used as a raw material for cosmetic or quasi-drug application.
  • component (A) to (C) in the composition a stable composition with higher concentration of bioactive ingredients is easily obtained by conventional method for personal-care and/or health care products.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A hydrophilic medium-soluble composition comprising (A) hydrophobic physiologically active ingredient (preferably, Minoxidil);(B) silicone compound having specific hydrophilic group (preferably polyether group); and (C) silane having specific hydrophilic group (preferably polyether group). Insoluble hydrophobic physiologically active ingredient are stabilized by a combination of said component (B) and (C) in the hydrophilic medium selected from water, alcohols and a mixture thereof without crystallization. The obtained clear hydrophilic medium-soluble composition is useful as a cosmetic raw material or quasi-drug raw material.

Description

STABLE HYDROPHILIC MEDIUM-SOLUBLE COMPOSITION AND THE USE THEREOF
[0001] The present invention relates to a stable hydrophilic medium-soluble composition of a hydrophobic physiologically active ingredient comprising (A) hydrophobic physiologically active ingredient; (B) silicone compound having specific hydrophilic group (preferably polyether group); and (C) silane having specific hydrophilic group (preferably, having at least two or more polyether group in a silane molecule). Insoluble hydrophobic physiologically active ingredient are stabilized by a combination of said component (B) and (C) in the hydrophilic medium selected from water, alcohols and a mixture thereof without crystallization. The obtained clear hydrophilic medium-soluble composition is useful as a cosmetic raw material or quasi-drug raw material in the personal and health care industries. Preferably, the hydrophobic physiologically active ingredient is hair-growing agent (ex. Minoxidil), and the hydrophilic medium-soluble composition is applied as a raw material for hair cosmetics or quasi-drugs for human skin of the head.
Background Of The Related Art
[0002] Having its bioactive efficacy to human body, hydrophobic physiologically active ingredient are widely incorporated into a formulation of cosmetics, quasi-drugs or medicines. Generally speaking, a personal-care and/or health-care product with higher concentration of such bioactive components is expected to have a stronger benefit to human body as on its proposed cosmetic and/or clinical uses of active ingredients. However, for its poor solubility into a biologically-acceptable hydrophilic medium, it is difficult to provide a personal-care and/or health-care product with high concentration of physiologically active ingredients.
[0003] Especially, Minoxidil (6-piperidin-l-ylpyrimidine-2, 4-diamine 3-oxide) or other water-insoluble hair growing agent is a vasodilator medication known for its ability to slow or stop hair loss and promote hair re-growth. It is available over the counter for treatment of androgenic alopecia, among other baldness treatments. Then, Minoxidil needs to be applied once or twice daily for the hair gain to be maintained. For maximum effect, the solution should be in contact with the scalp for four hours before being washed out. It does not seem capable of reducing dihydro testosterone (DHT) or the enzyme responsible for its accumulation around the hair follicle, 5-alpha reductase, which are the main causes of male pattern baldness in genetically susceptible individuals. Therefore, when treatment is stopped, the DHT already accumulated around the follicle has its expected effect, and the follicle usually shrinks again and eventually dies. To avoid such result, one effective option is to apply Minoxidil solution in highly-concentrated form.
[0004] However, as same as other hydrophobic physiologically active ingredient, Minoxidil has poor solubility in water or other hydrophilic medium. For this, it is difficult to increase the concentration of physiologically active ingredient to 5 or more % in the solution. Furthermore, during its storage term, insoluble active ingredients are precipitated in the product and caused a heavy crystallization. Furthermore, the obtained Minoxidil solution appears to be unclear and its acceptable usage is fairly limited in a personal-care and/or health-care product. Additionally, Minoxidil products involve contact with hair strands, which may cause problems with hair styling since minoxidil must be in an alcohol solution and on evaporation minoxidil is crystallized and on light exposure, converts to dark brown material. This is one of the biggest challenges for formulators to keep minoxidil in soluble form after applications.
[0005] To improve the stability and/or solubility of Minoxidil or other hydrophobic physiologically active ingredient, some patent documents proposed to use silicone material in the solution form. For example, WO2009/101497 discloses a fixed topical composition which contains minoxidil, aminexil, siloxanes, and silicone elastomers. WO03055454A1 teaches to the use of lipophillic components selected from fatty acids comprising 14-20 carbon atoms and dimethyl polysiloxane (mixtures thereof).
[0006] The combination of silicones (especially, Silicone Poly Ether), ethanol and Minoxidil in hair cosmetics are disclosed in JP 11012136 (practical example 3) and JP2001302543 (practical example8). Furthermore, JP2000-313808 also teach that some Silicone Poly Ether improve water-soubility of cosmetic components.
[0007] On the other hand, US6740318 teach an efficacy-enhancing additive (specific silicone based compound) for hair growing agent and a hair growing agent composition containing it. The additive is capable to secure the hair growing effect, even if the content of the pharmaceutically active components is reduced from that of the conventional hair growing agent composition, hence the side-effect thereof could be reduced, and to the hair growing agent composition containing it.
[0008] However, these patents failed to disclose inventive combination of specific hydrophilic silicone, specific hydrophilic silane and bioactive ingredients that helps to prepare a clear solution. Furthermore, these patents cannot sufficiently improve the solubility of bioactive ingredients (ex. Minoxidil) in the solution form. Specifically, through the suggestion or disclosed combination in these related arts, it is impossible to obtain a stable and clear Minoxidil solution with 5 or more % concentration of active ingredient.
Summary Of The Invention
[0009] The present inventors have found that hydrophobic physiologically active ingredient is effectively stabilized by using a combination of specific hydrophilic silicone and specific hydrophilic silane in a clear solution. Furthermore, with said combination of three components, hydrophilic medium-soluble composition with high-content of bioactive ingredient is easily obtained by conventional method for personal-care and/or health care products. The obtained composition appears to be clear and stable after storage without any crystallization of bioactive ingredients.
[0010] The invention is for a stable hydrophilic medium-soluble composition of a hydrophobic physiologically active ingredient comprising:
(A) at least one of hydrophobic physiologically active ingredient;
(B) at least one silicone compound having a hydrophilic group which binds to a silicone atom via a linkage group with two or more valences and comprise at least one hydrophilic unit selected from hydrophilic units represented by the following structural formulae (1) to (4):
-CrH2r-0- (1)
wherein r is a number ranging from 1 to 6,
-CH2-CH(OCH2-OW)-0- (2)
wherein W represents a hydrogen atom or an Ci-C20 alkyl group,
-CH(OCH2-OW)- CH2-0- (3) wherein W represents the same group as defined above,
- CH2-CH(OH)-CH2-0- (4) ; and
(C) at least one silane having a hydrophilic group which binds to a silicone atom via a linkage group with two or more valences and comprise at least one hydrophilic unit selected from hydrophilic units represented by said structural formulae (1) to (4).
[00111 Preferably, said components (A) to (C) are dispersed into (D) hydrophilic medium selected from water, alcohols and a mixture thereof in the composition. The preferred component (A) is water-insoluble hair-growing agent (ex. Minoxidil), the preferred component (B) is polyether-modified silicone represented by specific structural formulae, and the preferred component (C) is polyether-modified silane having two or more polyether groups in a silane molecule. Optionally, the composition further comprises (E) an organic acid to adjust its pH into acidic state.
[0012] The preferred weight ratio of each components in the composition is as followings:
the amount of component (A) is 0.5 to 30 % by weight of total amount of the composition, the amount of component (B) is 1.0 to 30 % by weight of total amount of the composition, the amount of component (C) is 0.1 to 10 % by weight of total amount of the composition.
Especially, with an inventive combination of component (A) to (C) in the composition, the amount of component (A) is increased to 5.0 or more % by weight of total amount of the composition. Most preferable weight range of component (A) is from 7.5 to 15.0 % by weight of total amount of the composition.
Detailed Description of the Invention
[0013] The present invention relates to a stable hydrophilic medium-soluble composition of a hydrophobic physiologically active ingredient comprising:
(A) at least one of hydrophobic physiologically active ingredient;
(B) at least one silicone compound having a hydrophilic group which binds to a silicone atom via a linkage group with two or more valences and comprise at least one hydrophilic unit selected from hydrophilic units represented by the following structural formulae (l) to (4):
-CrH2 O- (1)
wherein r is a number ranging from 1 to 6,
-CH2-CH(OCH2-OW)-0- (2)
wherein W represents a hydrogen atom or an Ci-C2o alkyl group,
-CH(OCH2-OW)- CH2-0- (3)
wherein W represents the same group as defined above,
- CH2-CH(OH)-CH2-0- (4) ; and
(C) at least one silane compound having a hydrophilic group which binds to a silicone atom via a linkage group with two or more valences and comprise at least one hydrophilic unit selected from hydrophilic units represented by said structural formulae (l) to (4).
[0014] Component (A) is at . least one of water-insoluble hair-growing agent.
Preferably component A is Minoxidil.
Figure imgf000006_0001
Other applicable hair-growing agent can be exemplified by water-insoluble hair-growing agents such as mononitroguaiacol, resorcinol, g-aminobutyric acid, benzethonium chloride, mexiletine hydrochloride, auxin, female hormones, cantharis tincture, cyclosporine, zinc pyrithione, hydrocortisone, polyoxyethylene sorbitan monostearate, peppermint oil, and sasanishiki extract. Preferably, two or more hair-growing agents may be used in combination for advantageous hair-growing effect on human scalp. [0015] Component (B) is a silicone compound having a hydrophilic group such as polyether-modified silicones, mono- or polyvalent alcohol-modified silicones, monoglycerol-modified silicones, diglycerol-modified silicones, polyglycerol-modified silicones, sugar-alcohol modified silicones, polysiloxane-polyoxyalkylene block copolymers.
[0016] From the viewpoint of stabilization of hydrophobic physiologically active ingredient in the solution, most preferable polyether-modified silicone (B2) is represented by the following structural formulae (5):
Figure imgf000007_0001
Wherein 1 independently represents C1-C20 alkyl group or phenyl group, Q represents polyether group represented by following formula (6):
-(C2H40),i(C3H60)t2-W (6)
Wherein each of tl and t2 is independently a number of 0 or more,
tl+t2 is a number ranging from 4 to 50, preferably 6 to 30,
W represents a hydrogen atom or an Ci-C2o alkyl group, preferably a hydrogen atom or methyl group,
R is a group selected from R1, Q and -OH,
m is a number ranging from 3 to 100, preferably 4 to 80, more preferably 5 to 50 n is a number ranging from 1 to 50, preferably 1 to 30, more preferably 1 to 20.
[0017] Component (C) is a silane compound having a hydrophilic group. Preferably, the silane compound has two or more defined hydrophilic group in a molecule. Other groups binding to Si atom may be selected from Ci-C20 alkyl group, phenyl group, hydroxyl (- OH) group, C1-C4 alkoxy group and Chloride. Hydrophilic group of component (C) is preferably selected from polyether-group, mono- or polyvalent alcohol- group, monoglycerol- group, diglycerol- group, polyglycerol- group and sugar-alcohol group. [0018] Component C may be a polyether-modified silane. Preferably, the silane has two or more defined hydrophilic group in a molecule and represented as following:
Si (R2)p {CrH2r-(C2H40)tl(C3H60)t2-W}4-p
Wherein tl and t2 is independently a number of 0 or more,
tl+t2 is a number ranging from 4 to 50, preferably 6 to 30,
r is a number of 1 to 6, preferably 2 to 3,
p is a number of 2 to 4, preferably 2 to 3, most preferably 2,
R2 independently represents Ci-C20 alkyl group, phenyl group, hydroxyl(-OH) group, d- C4 alkoxy group or Chloride, Preferably R2 independently represents methyl group or ethyl group,
W represents a hydrogen atom or an C1-C20 alkyl group, preferably a hydrogen atom or methyl group.
[0019] The hydrophilic medium-soluble composition Component (D) is a hydrophilic medium selected from water, alcohols and a mixture thereof. Preferably, water, ethanol, isopropanol, 1,3-butylene glycol, sorbitol, dipropylene glycol, glycerol, and polyethylene glycol may be used as component (D) that are able to increase the stability of the inventive composition. More preferably, water, 1,3-butylene glycol, sorbitol, dipropylene glycol, glycerol, and polyethylene glycol may be used as component (D) as they additionally have a moisturizing effect. The water should be clean and free of components toxic to humans and can be exemplified by tap water, purified water, and mineral water. The combination of water and a non-water component (D), as described above, mixed at an optional mass ratio from 0.1/9.9 to 9.9/0.1, is also preferred for the cosmetic or quasi-drug application.
[0020] The hydrophilic medium-soluble composition may further comprise Component (E) which is preferably organic acids. The organic acidmay be selected from the group consisting of acetic acid, lactic acid, citric acid, ascorbic acid, malic acid, tartaric acid, and so forth.
[0021] The pH should be adjusted, preferably in the ranges from 2 to 7 (acidic) to stabilize component (A). Component (A) is much stable at lower pH. [0022] The weight ratio of component (A), (B), and (C) in the composition preferably ranges from 0.5 to 30 % by weight of total amount of the composition, from 1.0 to 30 % by weight of total amount of the composition, and from 0.1 to 10 % by weight of total amount of the composition, respectively.
[0023] The advantages of this inventive composition lies in the fact that higher concentration (5 or more %) of component (A) leads to temporal stability after storage, and results in clear, crystallization-free composition wherein minoxidil remains in soluble form after application. The composition of the present invention has the capability to be used in personal-care and/or health-care products.
[0024] Other suitable cosmetic, quasi-drug ingredients may also be incorporated in the composition. Namely, the composition of the present invention can comprise any combination of the aforementioned components (A) to (D) and at least any one of the following components; oil agents (including fats and oils, higher fatty acids, higher alcohols, fluorine-based oils and the like); other surfactants (at least one type selected from the group consisting of anionic surfactants, cationic surfactants, nonionic surfactants, amphoteric surfactants and semi-polar surfactants); water-soluble polymers; thickening and/or gelling agents; powders; solid silicone resins or crosslinking organopolysiloxanes; UV-ray protective components; oxidation hair dyes; direct dyes; organic resins, moisture- retaining agents, preservative, anti-microbial agents, perfumes, salts, oxidants or antioxidants, pH adjusting agents, chelating agents, algefacients, anti-inflammatory agents, physiologically active components (such as whitening agents, cell activators, agents for ameliorating skin roughness, blood circulation accelerators, astringents, antiseborrheic agents and the like), vitamins, amino acids, nucleic acids, hormones, clathrate compounds, natural plant extract components, seaweed extract components, herb components, volatile solvents and the like.
[0025] The most preferred form of using the composition is when the composition comprises Minoxidil in high concentration and is applied to human hair or human scalp as cosmetic or a quasi-drug for scalp treatment. The forms of the cosmetic or quasi-drug of the present invention are not particularly restricted, and may be in the form of liquids, creams, solids, pastes, gels, powders, lamellas, mousses, sprays, sheets, and the like. The cosmetic or quasi-drug of the present invention can be exemplified by hair-restoring agents, hair growth agents, hair tonics, hair oil, skin ageing inhibitors, scalp-care oils, scalp soap, scalp cleansing agents, scalp treatment agents, ointments, shampoos, rinses, hair- treatments and the like but are not limited to the preceding.
Examples
[0026] The following examples demonstrate embodiments of the invention. It should be appreciated by those of skill in the art that the techniques disclosed in the examples which follow represent techniques discovered by the inventor to function well, in the practice of the invention, and thus may be considered to constitute typical modes for its practice. However, those skilled in the art should, in light of the present disclosure, appreciate that modifications may be made in the specific embodiments which are disclosed and still obtain a like or similar result without departing from the spirit and scope of the invention. All percentages are in wt. %.
[0027] Example 1 : Preparation of Minoxidil-comprising composition
As shown in following Table 1, each of the components were soaked and stirred to have a clear solution. Table 1 shows the effect of solubility of Minoxidil in various component (a) or (b) and crystallization and degradation observations.
[0028] Table 1
No Component Component Compone Lactic Solubility Clarity Crystalli
(B) (C) nt (A) acid zation
(E)
Minoxidil
1 SPE(bl) SAW(cl) 10% 5 % Soluble Clear No
(3%) (1%)
2 SPE(b2) SAW(cl) 10% 2 % Soluble Clear No (3%) (1%) 1
3 SPE(bl) SAW(cl) 10% 2 % Soluble Clear No (6%) (1%)
4 SPE(b2) SAW(cl) 10% 2 % Soluble Clear No (6%) (1%)
SPE (bl) is PEG-12 Dimethicone represented by bellow formula:
Figure imgf000011_0001
Ql represents - (C2H40)i2H
SPE (b2) is polyether-modified silicone represented by bellow formula:
Figure imgf000011_0002
Q2 represents - (C2H40)i2(C3H60)i2-H
SAW (cl) is Bis-PEG(18) mehyl ethyl Dimethyl silane.
[0029] Further as the SPE concentration is increased, lactic acid concentration may be reduced to have a stable formulation. This clearly indicates that SPEs work as solubilizing aid for hydrophobic drug like Minoxidil. Several formats like Gel, solution and Foam were developed by this concept and all the formulations were found stable during stability study.
[0030] Example 2 : Formulation for 10% Minoxidil Gel
Ingredients % wt
Phase A
Carbopol 940 (2% solution in water) Phase B
PEG-12 Dimethicone *1 5.0
Bis PEG-18 methyl ether dimethyl silane 1.0
Propylene glycol Q.S.
Ethanol 30.0
Benzyl alcohol 3.0
Hydrolyzed Keratin 1.0
Minoxidil 10.0
DI water 20.0
2-amino-2-methyl- 1 -propanol 1.0
* 1 PEG-12 Dimethicone is represented by below formula:
Figure imgf000012_0001
Ql represents - (C2H40)]2H
Procedure:
Carbopol 940™ 2% solution was prepared in water to obtain Phase A. Phase B was prepared by first mixing Minoxidil, Benzyl alcohol, Propylene glycol, Ethanol and water together. The mixture was stirred till clear solution was obtained. SPE (bl) and SAW (cl) were added in the mixture and stirred. All other ingredients were added to obtain a clear gel.
[0031] Example 3 : Formulation for 10% Minoxidil foam
Ingredients % wt
Phase A
Minoxidil 10.0 PEG- 12 Dimethicone * 1 6.0
Bis PEG- 18 methyl ether dimethyl silane 1.0
Propylene glycol 10.0
Ethanol 35.0
Benzyl alcohol 2.00
Lactic acid 5.00
Polysorbate 60 0.4
Glycerin q.s.
Water 10.00
Phase B
Hydrolyzed Keratin 1.00
Butylated hvdroxytoluene 0.10
Cetvl alcohol 3.00
Stearvl Alcohol 2.5
Perfume 0.05
Tetra fluoro ethane (HFA 1349) 10.0
*1 PEG- 12 Dimethicone is represented by below formula:
Figure imgf000013_0001
Ql represents -
Figure imgf000013_0002
Procedure
Phase A was prepared by mixing Minoxidil, Benzyl alcohol, Propylene glycol, Ethanol and water together. The mixture is stirred till a clear solution is obtained. SPE (bl) and SAW (cl) were added in the same and stirred. All other ingredients were added to get a clear solution. Phase B was prepared and added to Phase A slowly and packed with tetra fluroethene to get a stable foam. [0032] Example 4 : Formulation for 10% Minoxidil Solution (hydrous)
Ingredients %wt
Phase A
Propylene Glycol 30.0
Ethanol q.s.
Benzyl Alcohol 2.0
Ethoxylated Laiiryl Alcohol 5.0
Hydrolyzed Keratin 1.0
Phase B
PEG-12 Dimethicone 10.0
Bis PEG-18 Methyl Ether 2.0
Dimethyl Silane
Phase C
Anhydrous Citric Acid 2.0
DI Water 5.0
Phase D
Minoxidil 10.0
Procedure
All the ingredients of Phase A, Phase B, and Phase C were mixed in a separate beaker. Phase B was added to Phase A solution and stirred till a clear solution was obtained. Phase C was added to Phase A-Phase B mixture and stirred till a clear solution is obtained. This solution was heated for about 40-45°C and the temperature was maintained. Minoxidil was added to the above solution slowly, while continuously stirring it for 20 minutes till a clear solution is obtained. The clarity must be checked to ensure complete dissolution of the drug.
[0033] Example 5 : Formulation for 10% Minoxidil solution (anhydrous)
ingredients'
Phase A
Propylene Glycol 30.0
Ethanol q.s.
Benzyl Alcohol 3.0
Ethoxylated Lauryl Alcohol 5,0
Hydrolyzed Keratin 1.0
Anhydrous Citric Acid 2.0
Phase B
PEG- 12 Dimethicone 5.0
Bis PEG-IS Methyl Ether 1.0
Dimethyl Silane
Phase C
Minoxidil 10.0
Procedure
All the ingredients of Phase A, Phase B, and Phase C were mixed in a separate beaker. Phase B was added to Phase A solution and stirred till a clear solution was obtained. This solution was heated for about 40-45°C and the temperature was maintained. Minoxidil was added to the above solution slowly, while continuously stirring it for 20 minutes till a clear solution is obtained. The clarity must be checked to ensure complete dissolution of the drug.
[0034] Example 6 .- Formulation for 10% Minoxidil solution (anhydrous)
Ingredients % wt
Phase A
Propylene glycol 30.0
Ethanol q.s.
Benzyl alcohol 3.0
Ethoxylated Lauryl Alcohol 5.0
Hydrolyzed Keratin 1.0
Anhydrous Citric Acid 2.0
Phase B PEG- 12 Dimethicone 6.0
Bis PEG-18 methyl ether dimethyl silane 1.0
Phase C
Minoxidil 10.0
Procedure
All the ingredients of Phase A, Phase B, and Phase C were mixed in a separate beaker. Phase B was added to Phase A solution and stirred till a clear solution was obtained. This solution was heated for about 40-45°C and the temperature was maintained. Minoxidil was added to the above solution slowly, while continuously stirring it for 20 minutes till a clear solution is obtained. The clarity must be checked to ensure complete dissolution of the drug.
Industrial Applicability and Advantages Of The Invention
[0035] The instant invention relates to a stable hydrophilic medium-soluble composition of a hydrophobic physiologically active ingredient having excellent compatibility with hydrophilic medium and maintains a clear appearance after storage at a high concentration of said active ingredient. The said composition may be used as a raw material for cosmetic or quasi-drug application. Furthermore, with aforementioned combination of component (A) to (C) in the composition, a stable composition with higher concentration of bioactive ingredients is easily obtained by conventional method for personal-care and/or health care products.

Claims

1. A stable hydrophilic medium-soluble composition of a hydrophobic physiologically active ingredient comprising:
(A) at least one of hydrophobic physiologically active ingredient;
(B) at least one silicone compound having a hydrophilic group which binds to a silicone atom via a linkage group with two or more valences and comprise at least one hydrophilic unit selected from hydrophilic units represented by the following structural formulae (1) to (4):
-CrH2r-0 (1)
wherein r is a number ranging from 1 to 6,
-CH2-CH(OCH2-OW)-0- (2)
wherein W represents a hydrogen atom or an Ci-C2o alkyl group,
-CH(OCH2-OW)- CH2-0- (3)
wherein W represents the same group as defined above,
- CH2-CH(OH)-CH2-0- (4) ; and
(C) at least one silane compound having a hydrophilic group which binds to a silicone atom via a linkage group with two or more valences and comprise at least one hydrophilic unit selected from hydrophilic units represented. by said structural formulae (l) to (4).
2. The stable hydrophilic medium-soluble composition of claim 1, wherein hydrophilic medium (D) selected from water, alcohols and a mixture thereof.
3. The stable hydrophilic medium-soluble composition of claim 1 or claim 2, further comprises (E) an organic acid.
4. The stable hydrophilic medium-soluble composition of any one of claim 1 to 3, wherein the component (A) is at least one of water-insoluble hair-growing agent (Al), the component (B) is at least one of polyether-modified silicone (Bl),
and the component (C) is at least one of polyether-modified silane (CI).
5. The stable hydrophilic medium-soluble composition of any one of claim 1 to 4, wherein the component (A) is Minoxidil (A2), the component (B) is at least one of polyether-modified silicone (B2) represented by the following structural formulae (5):
Figure imgf000018_0001
Wherein R1 independently represents C C20 alkyl group or phenyl group, Q represents polyether group represented by following formula (6):
-(C2H40)«,(C3H60)t2-W (6)
Wherein each of tl and t2 is independently a number of 0 or more, tl+t2 is a number ranging from 4 to 50, W represents a hydrogen atom or an Ci-C 0 alkyl group,
R is a group selected from R1, Q and -OH,
m is a number ranging from 3 to 100, n is a number ranging from 1 to 50.
and the component (C) is at least one of polyether-modified silane having two or more polyether groups represented by said formula (6) in a molecule (B2).
6. The stable hydrophilic medium-soluble composition of any one of claim 1 to 5, wherein the amount of component (A) is 0.5 to 30 % by weight of total amount of the composition,
the amount of component (B) is 1.0 to 30 % by weight of total amount of the composition,
the amount of component (C) is 0.1 to 10 % by weight of total amount of the composition.
7. A cosmetic raw material or quasi-drug raw material comprising the stable hydrophilic medium-soluble composition of any one of claim 1 to 6.
8. A cosmetic composition or quasi-drug composition comprising the stable hydrophilic medium-soluble composition of any one of claim 1 to 6.
9. The cosmetic composition or quasi-drug composition of claim 8, wherein the composition is useful for application to human hair or human scalp.
PCT/IN2013/000515 2012-12-04 2013-08-26 Stable hydrophilic medium-soluble composition and the use thereof WO2014087421A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3429MU2012 2012-12-04
IN3429/MUM/2012 2012-12-04

Publications (2)

Publication Number Publication Date
WO2014087421A2 true WO2014087421A2 (en) 2014-06-12
WO2014087421A3 WO2014087421A3 (en) 2014-12-24

Family

ID=49887024

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2013/000515 WO2014087421A2 (en) 2012-12-04 2013-08-26 Stable hydrophilic medium-soluble composition and the use thereof

Country Status (1)

Country Link
WO (1) WO2014087421A2 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1112136A (en) 1997-06-27 1999-01-19 Taisho Pharmaceut Co Ltd Minoxidil-formulated aerosol
JP2000313808A (en) 1999-04-28 2000-11-14 Shiseido Co Ltd Solubilizing composition
JP2001302543A (en) 2000-04-27 2001-10-31 Lion Corp Hair quality improving agent
WO2003055454A1 (en) 2001-12-21 2003-07-10 Ponsus Pharma Ab New composition
US6740318B2 (en) 2000-04-04 2004-05-25 Nippon Unicar Company Limited Additive for hair growing agent and hair growing agent composition
WO2009101497A2 (en) 2008-02-11 2009-08-20 Glenmark Pharmaceuticals Limited Topical pharmaceutical combination comprising minoxidil and aminexil

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403067B1 (en) * 2000-05-19 2002-06-11 Colgate-Palmolive Company Stable emulsions for cosmetic products
US20040034094A1 (en) * 2002-08-16 2004-02-19 Gupta Shyam K. Vitamin C stabilized topical formulation
DE102004048987B3 (en) * 2004-10-04 2005-12-15 Coty Deutschland Gmbh Cooling cosmetic composition and its use
KR101444689B1 (en) * 2008-02-25 2014-09-26 (주)아모레퍼시픽 Whitening cosmetic composition
DE102008035834A1 (en) * 2008-07-31 2010-02-04 Coty Prestige Lancaster Group Gmbh Process for the preparation of liposome complexes with different active substances and products produced therewith, in particular cosmetic products
EP2461871A2 (en) * 2009-08-06 2012-06-13 Peter Thomas Roth Labs, Llc Compositions for promoting a healthy appearance of the skin
KR20120019409A (en) * 2010-08-25 2012-03-06 주식회사 엘지생활건강 Solid-type cosmetic composition for moisturizing
KR101467740B1 (en) * 2011-12-01 2014-12-01 가부시키가이샤 시세이도 Aqueous cosmetic preparation for skin

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1112136A (en) 1997-06-27 1999-01-19 Taisho Pharmaceut Co Ltd Minoxidil-formulated aerosol
JP2000313808A (en) 1999-04-28 2000-11-14 Shiseido Co Ltd Solubilizing composition
US6740318B2 (en) 2000-04-04 2004-05-25 Nippon Unicar Company Limited Additive for hair growing agent and hair growing agent composition
JP2001302543A (en) 2000-04-27 2001-10-31 Lion Corp Hair quality improving agent
WO2003055454A1 (en) 2001-12-21 2003-07-10 Ponsus Pharma Ab New composition
WO2009101497A2 (en) 2008-02-11 2009-08-20 Glenmark Pharmaceuticals Limited Topical pharmaceutical combination comprising minoxidil and aminexil

Also Published As

Publication number Publication date
WO2014087421A3 (en) 2014-12-24

Similar Documents

Publication Publication Date Title
KR101729100B1 (en) Foam-type external skin preparation
JP4418976B2 (en) Antiseptic disinfectant and cosmetic composition
WO2003002074A1 (en) Emulsion compositions
JP2012520317A (en) Thickening additive composition
JP5550863B2 (en) Cosmetics
JP5302239B2 (en) Antiseptic disinfectant and human body composition
JP2012504616A (en) Skin product and method for preventing static electricity
EA030316B1 (en) Cosmetic composition for applying to scalp
EP2832345B1 (en) Cosmetic composition
JP2002193755A (en) Antidandruff and anti-itching hair cosmetic and hair- shampooing cosmetic
KR102367688B1 (en) Transparent hair cosmetic composition
JP6445981B2 (en) Sunscreen composition comprising fatty acid and nonionic linear polymer
JP5455292B2 (en) Skin external composition
JP2003095843A (en) Nonaqueous cosmetic
JP5264829B2 (en) Antiseptic disinfectant and cosmetic composition
WO2014087421A2 (en) Stable hydrophilic medium-soluble composition and the use thereof
WO2002028361A2 (en) Compositions for cleansing skin and treating acne
JP2007161654A (en) Antiseptic microbicide, cosmetic or medicine comprising the same antiseptic microbicide formulated therein and antiseptic microbicidal method
JP2004067626A (en) External preparation composition
JP7256624B2 (en) Gel-form external preparation for skin or skin cosmetics
JP6774046B2 (en) Hair restorer composition
KR101904708B1 (en) Sparkling cosmetic composition for cleansing
RU2376981C2 (en) Sun-protection gel for face "sun fight" spf 35
JP2021054721A (en) Method for improving stickiness of adenosine-phosphate-containing composition
JP2011507942A (en) Novel esters and compositions and their use

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13815168

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 13815168

Country of ref document: EP

Kind code of ref document: A2